Submission Details
| 510(k) Number | K213063 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2021 |
| Decision Date | April 08, 2022 |
| Days to Decision | 197 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
K213063 is an FDA 510(k) clearance for the TLX SRAs and TLX Gold Abutments, a Abutment, Implant, Dental, Endosseous (Class II — Special Controls, product code NHA), submitted by Institut Straumann AG (Basel, CH). The FDA issued a Cleared decision on April 8, 2022, 197 days after receiving the submission on September 23, 2021. This device falls under the Dental review panel. Regulated under 21 CFR 872.3630.
| 510(k) Number | K213063 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2021 |
| Decision Date | April 08, 2022 |
| Days to Decision | 197 days |
| Submission Type | Traditional |
| Review Panel | Dental (DE) |
| Summary | Summary PDF |
| Product Code | NHA — Abutment, Implant, Dental, Endosseous |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 872.3630 |
| Definition | To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation. |